Katiuscia Bonezzi
C.V.

Pubblicazioni su riviste

Belgiovine C., Frapolli R., Bonezzi K., Chiodi I., Bavero F., Mello-Grand M., Dei Tos A., Giulotto E.,Taraboletti G., D’Incalci M. and Mondello C. Downregulation of RhoE promotes ROCK-dependent invasion in human sarcomagenic fibroblast. Plose One November 2010 | Volume 5 | Issue 11 | e14154

Taraboletti G., Bonezzi K., Giavazzi R. Combination therapy with chemotherapy and VDAs In: Vascular Targeting Therapy for Cancer. Meyer, T (Ed). Springer (New York, NY), in press, 2009

 

Bonezzi K., Taraboletti G., Borsotti P., Bellina F., Rossi R., Giavazzi R. Vascular Distrupting Activity of tubulin-Binding 1,5-Diaryl-1H-imidazole.Journal of medicinal chemistry (2009) 52, 7906-7910 IF: 4,898

Taraboletti G. and Bonezzi K. Inhibitors of angiogenesis based on thrombospondin-1. In: Recent advances in angiogenesis and antiangiogenesis. Ribatti D (Ed). Bentham Science, pp 112-126, 2009

Giavazzi R., Bonezzi K., Taraboletti G. Microtubule targeting agents and the tumor vasculature. In:  Microtubules as target for Cancer Therapies. Tito Fojo (Ed.), Human Press, Totowa, NJ;519-530, 2008

Margosio B., Rusnati M., Bonezzi K., Cordes A., Annis D.S., Urbinati C., Giavazzi R, Presta M., Ribatti D., Mosher D.F. and Taraboletti G. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain. Int J Biochem Cell Biol.(2008); 40(4):700-9 IF: 4,178

Martinelli M., Bonezzi K., Riccardi E., Kuhn E., Frapolli R., Zucchetti M., Ryan AJ, Taraboletti G. and Giavazzi R. Sequence dependent antitumour efficacy of the vascular distrupting agent ZD6126 in combination with paclitaxel. British Journal of Cancer (2007) 97, 888-894 IF: 4,635.

Congressi nazionali e internazionali

Bonezzi K. “Tubulin acetylation as a possible mechanism of the antiangiogenic activity of paclitaxel: implications for combination therapies with HDAC inhibitors”: Workshop SIICA Certosa di Pontignano (Siena) 10-12 Maggio, 2010

Poster

Bonezzi K., Giavazzi R., Taraboletti G., Modulation of tubulin acetylation affects the sensitive of endothelial cells to the antimotility effects of paclitaxel. 49th Annual Meeting of the Italian Cancer Society (SIC). Pordenone, November 26-29, 2007

Bonezzi K., North B., Manzotti C., Riva A., Verdin E., Giavazzi R., Taraboletti G. Tubulin acetylation and the antimotility effects of tubulin-targeting agents. 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Genève (CH), October 21-24, 2008

Bonezzi K., Cvitkovic E., Noel K., Giavazzi R., Taraboletti G. Antiangiogenic and antineoplastic activity of PTX-008, a nonpeptidic topomimetic of Anginex. 51st Annual Meeting of the Italian Cancer Society (SIC). Sesto S. Giovanni (MI) November 23-26, 2009


Coautrice delle seguenti presentazioni:

Borsotti P., Bonezzi K., Taraboletti G., Giavazzi R., Bellina F., Cauteruccio S., Rossi R. New tubulin-binding imidazole derivatives as vascular distrupting agents. International Conference on Vascular Targeted Therapies in Oncology. Mandelieu (Francia), October 4-6, 2007

Bonezzi K., Manzotti C., North B., Riva A., Giavazzi R., Verdin E., Taraboletti G. Tubulin-Targeting Agents as Inhibitors of Cell Motility. Joint Metastasis Research Society-AACR Conference on Metastasis Vancouver, BC, Canada August 3-7, 2008 

Belgiovine C., Frapolli F., Bonezzi K., Chiodi I., dei Tos P., Giulotto E., Taraboletti G., D’Incalci M., Mondello C. Changes in cell adhesion and motility during malignant transformaton of human fibroblasts 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine. Hersonissos, Crete, Greece October 9-11, 2008

Serova M., Bonezzi K., Raymond E., Bieche I., Faivre S., Astorgues-Xerri L., Cvitkovic E., Noel K., Giavazzi R., Taraboletti G. PTX-008, a non-peptidic topomimetic of the antiangiogenic galectin-1-targeting anginex: differential antiproliferative activity on cancer and endothelial cells. 100th AACR Annual Meeting. Denver (USA), April 18-22, 2009

Bonifacio S., Ghilardi C., Margosio B., Borsotti P., Bonezzi K., Taraboletti G. Overexpression of the FGF-2 binding domain of Thrombospondin-1 by ovarian cancer cells: consequences on their biologic behaviour. 51st Annual meeting of the Italian Cancer Society, Sesto San Giovanni (Milano), November 23-26, 2009